| Bruker Biospin GMBH, DE | Dr. Frank Engelke |
|---|---|
| TavarGenix, DE | |
| LifeGlimmer, DE |
Understanding metabolism in haematological cancer.

“This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 675790”.
| Bruker Biospin GMBH, DE | Dr. Frank Engelke |
|---|---|
| TavarGenix, DE | |
| LifeGlimmer, DE |